Phase 1 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with mild memory or thinking problems, or mild dementia, caused by early-onset Alzheimer's disease.
- Your memory and thinking abilities, as measured by standard medical tests, fall within a specific mild range (confirm with trial site).
Who may not be able to join:
- Your dementia is caused by something other than Alzheimer's disease.
- Your liver is not functioning within a normal healthy range, based on a blood test (confirm with trial site).
- Your kidneys are not filtering blood well enough, based on a blood test (confirm with trial site).
- You have recently taken part in another clinical trial and received an experimental treatment.
- You have recently been treated with a medication that targets amyloid, a protein linked to Alzheimer's disease (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Please note: Additional eligibility requirements not listed here may also apply, as stated by the trial organisers. Always check the full criteria with the trial team.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Alnylam Pharmaceuticals
Phone: 1-877-ALNYLAM
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part A: Frequency of Adverse Events; Part B: Frequency of Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.